|
|
 |
| |
 |
|
|
|
There are several elements to the safety profile of LifeCell products, some of which are related to donor eligibility, including donor blood testing for infectious diseases. LifeCell’s tissue processing adds significantly to the safety profile of the product, including substantially reducing the potential for viral contamination. LifeCell’s acellular process and patented preservation methodology have been shown in testing to reduce certain viruses by more than 99%. See Viral Safety Profile. In addition to viral safety, both incoming tissue and final products are screened and are negative for microbial pathogens. Lastly, LifeCell adheres to a stringently controlled and documented quality system that meets all regulatory standards.
LifeCell has more than 1 million grafts implanted with no confirmed cases of viral infectious disease transmission.
This information is for healthcare professionals only |
|
|
|
|